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EDITORIAL 
Introduction to Special Issue on Mitochondrial Redox Signaling in Health and Disease 
____________________________________________________________________________________________________________________ 
Mitochondria are functional entities that harbor the energy-conservation machinery that sup-
ports cell function through the coordination of mitochondrion-derived molecules involved in the 
regulation of cell signaling and transcription. Conversely, mitochondria are targets of an ever-
increasing number of signaling pathways and their activity is also modulated by several tran-
scription factors. The cell’s energy-redox homeostasis is primarily a function of mitochondrial 
oxidative phosphorylation and the formation of O2
.–
/H2O2.  Notably, other mitochondrion-driven 
processes contribute to cellular homeostasis, such as mitochondrial biogenesis and dynamics, mi-
tochondrial quality control (autophagy and mitophagy), mitochondrial proteostasis and the role 
of the mitochondrial unfolded protein response (UPR
mt
), and redox signaling in the homeostatic 
control of mitochondrial function. This Free Radical Biology & Medicine special issue on Mito-
chondrial Redox Signaling in Health and Disease covers some aspects of the myriad of process-
es embraced by mitochondrial biology and physiology, provides mechanistic insights linking mi-
tochondrial function with cell function, and recognizes mitochondrial function as an amenable 
therapeutic target. 
 
Energy metabolism: Mitochondria and the organelle network 
Mitochondrial function cannot be viewed as that originating from isolated organelles, for ex-
tensive cross-regulation of organelle function occurs at organelle contact sites, e.g., MAM (mito-
chondria-associated membranes) between mitochondria and ER [1]. Other organelle interactions 
involve the ER, Golgi apparatus, nucleus, plasma membrane and others, and are associated with 
the regulation of several cellular processes.  These organelle contact sites acquire further signifi-
cance when considering that they serve as a platform for cell signaling, as in the case of MAM 
alterations and processes associated with insulin resistance [2].  
The most important function of mitochondria is oxidative phosphorylation with formation of 
ATP to maintain the cell’s energy homeostasis: electrons flowing through the respiratory chain 
complexes linked with pumping of H
+
 across the inner mitochondrial membrane and energy con-
servation as a protonmotive force drives the synthesis of ATP. The complexity of the oxidative 
phosphorylation system has revealed the occurrence of supercomplexes with different propor-
tions of complexes I, III, and IV [3, 4], the formation of which is assisted by several assembly 
factors. The occurrence of two different coenzyme Q pools (one trapped within the supercom-
plex structure and another free in the inner mitochondrial membrane) serves to reconcile diverg-
ing experimental evidences under the plasticity model [5]. It may be surmised that supercomplex 
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organization is an adaptive mechanism of mitochondria to optimize their function in response to 
fuel availability and/or oxidant concentration [5]. Mitochondrial translation is essential for the 
oxidative phosphorylation system biogenesis and, consequently, for cellular energy supply. The 
synthesis of mtDNA-encoded polypeptide subunits of oxidative phosphorylation complexes is 
supported by a key quality control factor in mitochondrial translation, the mitochondrial transla-
tion factor 4 (mtEF4) [6], which –together with other translational activators– facilitates the 
crosstalk between mitochondrial translation and cytosolic translation, a process regulated by 
mTOR signaling  [6]. 
In addition to supercomplex organization, metabolic reprogramming is increasingly recog-
nized among the many enabling features that drive tumorigenesis and required to sustain prolif-
eration and affecting the tumor microenvironment: metabolites from the tricarboxylic acid cycle 
due to mutations of fumarate hydratase, succinate dehydrogenase, and isocitrate dehydrogenase –
termed oncometabolites – drive oncogenic signaling [7].  
Plant mitochondria exhibit the highest respiration rates during seed germination, pollen de-
velopment, and fruit ripening, i.e., mitochondria are key players in plant development and this 
high energy requirement is met by an increased number of mitochondria [8]. Bypass of the elec-
tron-transfer complexes of the respiratory chain by the alternative oxidase does not contribute to 
ATP generation but plays an important role in stress tolerance in plants, and this activity helps 
dissipate excess energy thus preventing formation of H2O2 [8]. 
 
Mitochondrial H2O2: The link between energy metabolism and redox biology 
The respiratory supercomplexes also have implications for mitochondrial O2
.–
 and H2O2 pro-
duction, e.g., oxidant production by complex I is lower when superassembled with complex III 
[5]. There are several sources of mitochondrial O2
.–
 and H2O2 within the NADH/NAD
+
 isopoten-
tial group (e.g., -ketoglutarate dehydrogenase, pyruvate dehydrogenase, and others) and the 
QH2/Q isopotential group (e.g., glycerol-P-dehydrogenase and acyl-dehydrogenase) in complex-
es I and III of the respiratory chain [9]. The highest rates of O2
.–
/H2O2 occur at the QH2/Q isopo-
tential group; a thorough analysis of the factors that lead to mitochondrial O2
.–
 production sug-
gested reverse electron transport at the level of complex I when the NADH/NAD
+
 ratio is high 
[10]. This underscores the significance of assessing the cellular and mitochondrial pyridine nu-
cleotide levels by genetically encoded NAD
+
/NADH sensors [11, 12] or fluorescence lifetime 
imaging microscopy (FLIM) [13]. The latter offers the potential to discriminate between the 
NAD and NADP pools and provides metabolic information into the changes of time-resolved 
(NAD(P)H fluorescence in pathophysiological situations [13].   
Mitochondrion-derived H2O2 is the most likely signal leading to short-term responses (redox 
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signaling) and long-term responses (redox regulation of transcription) [10]. H2O2-mediated redox 
regulation of signaling and transcription entails thiol/disulfide exchange reactions [14, 15]. In 
this special issue, mitochondrion-derived H2O2: (a) establishes a link between energy metabo-
lism and inflammatory responses [16], acting on redox-sensitive targets such as Nrf2, NFB, 
JNK, IIS [17, 18], and stimulates mitochondrial biogenesis [19]; (b) is at the interface between 
bioenergetics, autophagy, and circadian control [20]; (c) is controlled during cholesterol oxida-
tion in steroidogenic cells and brings together the coordinated activities of peroxiredoxin III –the 
major H2O2 reducing system within mitochondria– sulfiredoxin, which recovers hyperoxidized 
peroxiredoxin III [21]; (d) is involved in the activation of phospholipases and is an important 
physiological function associated with O2 sensing in astrocytes and regulation of breathing [22]; 
(e) regulates mitogenic cellular signaling in proliferating cells through HIF activation and tran-
scriptional activation of genes required for metabolic adaptations to proliferation and induction 
of angiogenesis [23]. It has been proposed that transducing an H2O2 signal can be accomplished 
by peroxiredoxin-2 and STAT3 [24]. 
Mitochondrial H2O2 production can be viewed as the integration of an energy component 
(acetyl-CoA as a metabolic hub, tricarboxylic acid cycle, respiratory chain) and a redox compo-
nent (mitochondrial NADPH-supported GSH- and thioredoxin-dependent antioxidant networks) 
into the energy-redox axis [18]. Hepatic GSH levels can be regulated by microRNAs by either 
targeting glutamate-cysteine ligase (GCL) or downregulating the levels of Nrf2, noting that 
miR433 is redox sensitive and downregulates the expression of GCL in an Nrf2-independent 
manner. The liver methionine pathway is also regulated by a specific set of miRNAs [25]. Im-
pairment of the integration of metabolism and redox biology entailed in the energy-redox axis re-
sults in mechanisms underpinning removal of damaged organelles (autophagy, mitophagy), i.e., 
quality control, which is monitored at the protein, organelle and sub-organelle levels [26]. Mi-
tophagy entails the coordinated activity of mitochondrial kinase PINK1 and the ubiquitin ligase 
Parkin that tag mitochondria for lysosomal degradation; conversely, USP30 deubiquitinase in-
hibits mitophagy by opposing Parkin-mediated ubiquitination [27].  Essential to mitochondrial 
quality control is the recognition of receptors that sense different signals and associate the mi-
tophagy machinery with mitochondrial dynamics [26]. Examples of mitophagy receptors are 
ATG32 (Autophagy-related protein 32), FUNDC1 (FUN14 domain-containing protein 1), and 
BCL2-L-13 (BCL-2-like protein 13) as well as others. Activation of these receptors is linked to 
the DRP1-driven mitochondrial fission machinery [26]. Signaling through these receptors can be 
triggered by bioenergetics deficits, hypoxia, oxidative stress and inflammation [26].  
O2
.–
 formation by mitochondria appears to be a requirement for activation of mitochondrial 
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poly(ADP-ribose) polymerase (mtPARP), thereby catalyzing the poly(ADP-ribosyl)ation 
(PARylation) of the electron transfer complexes and decreasing energy production [28]. In 
plants, H2O2 signaling is important in reproductive development, i.e., pollen germination, pollen 
tube growth and fertilization, and pollen maturation [8]. 
Another type of mitochondrion-driven signaling, not necessarily redox in nature, is accom-
plished by mt-DNA-encoded mitochondrial-derived peptides (MDPs), although mechanisms of 
mitochondrial export are still under investigation [29]. As a mitochondrial signal, MOTS-c (Mi-
tochondrial ORF within the Twelve S rRNA c) has several metabolic targets (folate-methionine 
cycle and related AMPK and sirtuin signaling), stimulates glucose uptake, regulates fat and mus-
cle metabolism [29].  
 
Mitochondrial function in neurodegenerative disorders 
Deficits in cell bioenergetics are a common denominator in several neurodegenerative disor-
ders as well as in aging. Alzheimer’s disease [17], Parkinson’s disease [30], Friedrich ataxia 
[31], among others, also share some aspects of impairment of glucose homeostasis and insulin 
resistance. In this special issue, impairment of oxidative phosphorylation and increased for-
mation of mitochondrial H2O2 in Parkinson’s disease leads to a compensatory increase in glycol-
ysis (upon oxidant-mediated stabilization of HIF-1) that, in turn, impairs pentose phosphate 
pathway activity [30]. This metabolic shift and oxidative damage in Parkinson’s disease also im-
pairs mitochondrial quality control pathways and leads to the consideration of Parkinson’s dis-
ease as a metabolic syndrome-like disorder [30]. The interconnected mitochondrial energy- and 
redox systems in mouse models of Alzheimer’s disease [17] are consequences of deficits in brain 
glucose availability, reduced oxidative phosphorylation, compensatory glycolysis, increased 
formation of mitochondrial H2O2, all leading to the bioenergetics hypothesis of Alzheimer’s dis-
ease. Thus, redox dysregulation is viewed in this sub-section as a common denominator and link 
to the inflammatory hypothesis, where microglia activation is considered as the driving force for 
neuroinflammation [17]. The genetic deficiency of the mitochondrial protein frataxin is the cause 
of Friedreich ataxia. Frataxin deficiency is not associated with cognitive impairment, but with 
increased oxidative stress with alterations in lipid metabolism, which are  discussed as potential 
therapeutic approaches in Friedreich ataxia [31]. The mitochondrial Lon protease is involved in 
several neurological disorders, such as hereditary Parkinson’s disease, Friedreich ataxia, familial 
amyotrophic lateral sclerosis, brain ischemia and stroke [32]. In these disorders, the physiologi-
cal functions of the Lon protease are altered: as a protease, as a chaperone,and as a mtDNA-
binding protein [32]. 
The involvement of mitochondrial dysfunction and oxidative stress in the pathogenesis of 
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several neurodegenerative diseases represent potential therapeutic targets. Concerning oxidative 
stress, astrocytes play a key role in providing antioxidant support to neurons [33] through redox 
regulation of the astrocytic Nrf2 pathway, whereas in neurons the synaptic activity-dependent 
expression of genes of the GSH and thioredoxin-peroxiredoxin families are the major antioxidant 
systems. Agonists of the peroxisome proliferation-activated receptor gamma (PPAR), a ligand-
activated transcription factor involved in the regulation of mitochondrial bioenergetics and turn-
over, antioxidant defenses, and immune responses, are important therapeutic agents in neuro-
degenerative diseases [34]. Mitochondrial sirtuins (SIRT3, SIRT4, SIRT5) have a variety of 
functions, deacetylase, ADP-ribosylase, lipoamidase, succinylation, glutarylation; hence, these 
sirtuins are involved in the regulation of a broad range of metabolic pathways and, as a corollary, 
implicated in a range of metabolic diseases, such as neurodegeneration, diabetes, cancer, cardiac 
dysfunction, and age-related disorders [35]. 
 
Mitochondrial genomics in health and disease 
Several mechanisms link mtDNA defects to atherosclerosis, and although a causative role of 
oxidants in the development of plaque formation has been widely reported, oxidative stress is not 
necessarily required for mtDNA damage to impact energy metabolism, lead to apoptotic cell 
death, activate inflammatory responses and promote atherogenesis [36]. In addition to mtDNA 
damage, defects in mt-translation elongation factors have been associated with several human 
diseases [6]. mtPARP is also involved in the repair of mtDNA by interacting with essential fac-
tors of the mtDNA repair machinery however, under oxidative stress conditions, excess of O2
.–
 
formation, mtPARP PARylates those essential factors, thereby promoting the disassembly of the 
mtDNA repair complex [28] and contributing to mtDNA oxidative damage. As mentioned above 
in mitochondrial signaling, the short open reading frames (sORFs) in mtDNA encode humanin 
and other small humanin-like peptides [29]. In plants, the highly dynamic nature and diversity of 
mtDNA has profound implications for response to stresses as well as development [8]. 
 
This Free Radical Biology & Medicine Special Issue on Mitochondrial Redox Signaling in 
Health and Disease covers only a small part of the many biological processes in which mito-
chondria operate as a cellular hub. The significance of mitochondrial function is increased be-
cause of the large number of mitochondrion-centric mechanisms accounting for pathophysiologi-
cal situations as well as the development of mitochondrial pharmacology [31, 34, 37].  The invit-
ed review articles in this Special Issue will be of interest to researchers in the field of mitochon-
drial redox signaling, including postdoctoral fellows and graduate students. The Editors’ long-
term objective is to provide readers with informed updates of this research field every 3-4 years 
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in Free Radical Biology & Medicine.  
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